Page last updated: 2024-09-04

moxifloxacin and carbostyril

moxifloxacin has been researched along with carbostyril in 83 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (carbostyril)	Trials (carbostyril)	Recent Studies (post-2010) (carbostyril)
3,157	552	1,690	12,855	1,323	5,611

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	27 (32.53)	18.2507
2000's	34 (40.96)	29.6817
2010's	13 (15.66)	24.3611
2020's	9 (10.84)	2.80

Authors

Authors	Studies
Andrews, JM; Boswell, FJ; Brenwald, NP; Wise, R; Woodcock, JM	1
Aldridge, KE; Ashcraft, DS	1
Andrews, JM; Boswell, FJ; Wise, R	2
Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV	1
Brueggemann, AB; Doern, GV; Kugler, KC	1
Fass, RJ	1
Chen, D; Prahalad, AK; Rosen, JE; Schluter, G; Spratt, TE; Williams, GM	1
Bowker, KE; Holt, HA; MacGowan, AP; Reeves, DS; Wootton, M	1
Appelbaum, PC; Jacobs, MR; Visalli, MA	1
Bauernfeind, A	1
Dalhoff, A; Stass, H	1
Capper, T; Klugman, KP	1
Bébéar, C; Bébéar, CM; Boudjadja, A; Renaudin, H	1
Hammerschlag, MR; Roblin, PM	1
Brück, W; Chen, V; Dalhoff, A; Kohlsdorfer, C; Nau, R; Schmidt, H; Schneider, O; Stuertz, K; Trostdorf, F	1
Eliopoulos, GM; Ferraro, MJ; Moellering, RC; Schülin, T; Wennersten, CB	1
Eliopoulos, GM; Souli, M; Wennersten, CB	1
Hoban, DJ; Karlowsky, JA; Zhanel, GG	1
Frimodt-Møller, N; Knudsen, JD; Ostergaard, C; Sørensen, TK	1
Dalhoff, A; Hoppe, JE; Pfründer, D	1
Edlund, C; Nord, CE; Sabouri, S	1
Al-Nawas, B; Shah, PM	1
Dalhoff, A; Kubitza, D; Schühly, U; Stass, H	1
Bonnafous, P; Grosset, J; Ji, B; Lounis, N; Maslo, C; Truffot-Pernot, C	1
Bergogne-Bérézin, E	1
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR	1
Ferguson, J; Man, I; Murphy, J	1
Biedenbach, DJ; Jones, RN; Pfaller, MA	1
Fabian, I; Halperin, D; Kletter, Y; Nagler, A; Shalit, I; Vasserman, E; Waldman, D	1
Barrett, JF; Chaniewski, S; Frosco, M; Hooper, DC; Lawrence, LE; Ryan, B; Yang, H	1
Appelbaum, PC; Bozdogan, B; Clark, CL; Davies, TA; Dewasse, B; Jacobs, MR; Nagai, K	1
Goldstein, EJ	1
Finegold, S; Goldstein, E; Gorbach, SL; Harrell, L; Hecht, DW; Jacobus, NV; Jenkins, S; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R	1
Barton, T; Bowlware, K; Hardy, RD; Iglehart, J; Katz, K; McCoig, CC; McCracken, GH; Michelow, IC; Rodriguez-Cerrato, V; Saavedra, J	1
Firsov, AA; Lubenko, IY; Portnoy, YA; Vostrov, SN; Zinner, SH	1
Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY	1
Ameyama, S; Shinmura, Y; Takahata, M	1
Ciottoli, GB; Crumb, WJ; Durando, L; Lacroix, P	1
Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S	1
Gebert, A; Maass, M; Rupp, J; Solbach, W	1
Hermsen, ED; Hovde, LB; Konstantinides, GN; Rotschafer, JC	1
Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A	1
Dashieva, DG; Elistratova, NA; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB	1
Michot, JM; Mingeot-Leclercq, MP; Seral, C; Tulkens, PM; Van Bambeke, F	1
Paramasivan, CN; Rahman, F; Sulochana, S	1
Niederman, MS	1
Marchese, A; Roveta, S; Schito, AM; Schito, GC	1
Kohno, S	1
Depta, JP; Pichler, WJ; Schmid, DA	1
Bolaños, M; Finegold, SM; Molitoris, D; Väisänen, ML	1
Black, JA; Moland, ES; Thomson, KS; Wickman, PA	1
Black, JA; Hanson, ND; Smith Moland, E; Thomson, KS; Wickman, PA	1
Breithardt, G; Cakir, Y; Eckardt, L; Engelen, MA; Haverkamp, W; Hilker, E; Milberg, P; Mönnig, G; Osada, N; Ramtin, S; Stypmann, J	1
Cox, SK	1
Gieffers, J; Rupp, J; Solbach, W	1
Hatou, S; Minagawa, Y; Yamada, M; Yoshida, J; Yoshida, T	1
Ceccarelli, M; Gameiro, P; Mach, T; Neves, P; Ruggerone, P; Spiga, E; Weingart, H; Winterhalter, M	1
Horstkotte, MA; Knobloch, JK; Mack, D; Rohde, H; Von Osten, H	1
Alam, MR; Garg, P; Gopinathan, U; Krishnaiah, S; Reddy, AK; Sharma, S	1
Fisher, LM; Laponogov, I; McAuley, KE; Pan, XS; Sanderson, MR; Sawhney, R; Sohi, MK; Thompson, AW; Veselkov, DA	1
Carda-Broch, S; Esteve-Romero, J; Rambla-Alegre, M	1
Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR	1
Drlica, K; Malik, M; Wang, X; Zhao, X	1
Hsueh, PR; Lee, PI; Yang, JC	1
Andreu, I; Aranda, A; Ariza, A; Blanca-Lopez, N; Doña, I; Mayorga, C; Rosado, A; Torres, MJ	1
Drollmann, AF; Harris, S; Jennings, S; Khindri, S; Sabo, R; Woessner, R	1
Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA	1
Aubry, A; Chauffour, A; Escolano, S; Henquet, S; Jarlier, V; Matsuoka, M; Veziris, N	1
Kumar, R; Madhumathi, BS; Nagaraja, V	1
Cetinkaya, B; Demirdag, K; Denk, A; Kalkan, A; Kilic, SS; Ozden, M	1
Freeman, J; Pilling, S; Vernon, J; Wilcox, MH	1
Gisbert, JP; Marin, AC; McNicholl, AG; Nyssen, OP	1
Cai, L; Feng, P; Liu, X; Wang, X; Yang, J; Zhang, X; Zong, Z	1
Bone, S; Conway, RJH; Cook, S; Hassan-Ibrahim, MO; Malone, C; Soni, S	1
Jensen, JS; Manhart, LE	1
Cabañas, R; Domínguez-Ortega, J; Fiandor, A; González-Muñoz, M; Lluch-Bernal, M; Loli-Ausejo, D; Vílchez-Sánchez, F	1
Alami, A; Bjerre, LM; Gravel, CA; Krewski, D; Mattison, D; Momoli, F; Taher, MK; Tsui, D	1
Areia, M; Barrio, J; Beglinger, C; Bordin, D; Boyanova, L; Bujanda, L; Buzas, GM; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernandez, M; Doulberis, M; Fernandez-Salazar, L; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Jurecic, NB; Kunovský, L; Kupčinskas, J; Lamy, V; Lanas, A; Lasala, JP; Leja, M; Lerang, F; Lucendo, AJ; Marcos-Pinto, R; Marlicz, W; Megraud, F; Milivojevic, V; Molina-Infante, J; Morain, CO; Niv, Y; Nyssen, OP; Ortuño, J; Pérez Aísa, Á; Phull, P; Puig, I; Rodrigo, L; Rokkas, T; Sarsenbaeva, AS; Shvets, O; Simsek, I; Smith, S; Tepes, B; Tonkić, A; Vaira, D; Venerito, M; Vologzhanina, L; Voynovan, I	1
Chi, Z; Pan, X; Tang, W; Yin, Y; Zhao, M	1
Gunardi, WD; Moehario, LH; Nainggolan, IM; Nathania, I; Nusatia, ACM; Tjoa, E; Yasmon, A	1
Fu, D; Geng, J; Jiang, J; Li, B; Lu, L; Ma, L; Meng, F; Qi, H; Shen, J; Sun, S; Yabo, SD	1
Bulychev, VV; Bulycheva, EV; Pashkova, NA	1

Reviews

2 review(s) available for moxifloxacin and carbostyril

Article	Year
Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-15, Volume: 41 Suppl 2 Topics: Aza Compounds; Community-Acquired Infections; Disease Management; Drug Resistance, Microbial; Fluoroquinolones; Humans; Infusions, Intravenous; Moxifloxacin; Pneumonia; Quinolines; Quinolones; Streptococcus pneumoniae; Treatment Outcome	2005
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Drugs, 2017, Volume: 77, Issue:7 Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones	2017

Article

Year

Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-15, Volume: 41 Suppl 2

Topics: Aza Compounds; Community-Acquired Infections; Disease Management; Drug Resistance, Microbial; Fluoroquinolones; Humans; Infusions, Intravenous; Moxifloxacin; Pneumonia; Quinolines; Quinolones; Streptococcus pneumoniae; Treatment Outcome

2005

Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.

Drugs, 2017, Volume: 77, Issue:7

Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones

2017

Trials

5 trial(s) available for moxifloxacin and carbostyril

Article	Year
Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing. Journal of chromatography. B, Biomedical sciences and applications, 1997, Nov-21, Volume: 702, Issue:1-2 Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Biological Assay; Body Fluids; Chromatography, High Pressure Liquid; Circadian Rhythm; Drug Stability; Fluoroquinolones; Humans; Light; Male; Moxifloxacin; Osmolar Concentration; Quinolines; Quinolones; Reproducibility of Results; Saliva; Spectrometry, Fluorescence; Temperature; Time Factors	1997
Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:8 Topics: Adult; Anti-Infective Agents; Aza Compounds; Blood Proteins; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Male; Middle Aged; Models, Biological; Moxifloxacin; Quinolines; Quinolones; Saliva	1998
Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers. The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl B Topics: Adult; Anti-Infective Agents; Aza Compounds; Dermatitis, Phototoxic; Double-Blind Method; Fluoroquinolones; Humans; Male; Moxifloxacin; Photosensitizing Agents; Quinolines; Quinolones	1999
In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy, 2011, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Basophil Degranulation Test; Ciprofloxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Immediate; Immunologic Tests; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Radioimmunoassay; Sensitivity and Specificity; Young Adult	2011
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study. BMC pulmonary medicine, 2011, May-26, Volume: 11 Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aza Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart; Humans; Indans; Male; Middle Aged; Moxifloxacin; Quinolines; Quinolones; Young Adult	2011

Other Studies

76 other study(ies) available for moxifloxacin and carbostyril

Article	Year
In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Moxifloxacin; Protein Binding; Quinolines; Quinolones	1997
Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones	1997
Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones	1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7 Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Wound Infection	1997
In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7 Topics: Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Quinolines; Quinolones; Streptococcus pneumoniae	1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:8 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas aeruginosa; Quinolines; Quinolones; Regression Analysis	1997
A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation. Toxicology and applied pharmacology, 1997, Volume: 145, Issue:2 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Aza Compounds; Cell Line; Deoxyguanosine; Epithelium; Fluoroquinolones; Liver; Moxifloxacin; Quinolines; Quinolones; Rats; Ultraviolet Rays	1997
Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones	1997
Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12 Topics: Administration, Oral; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefpodoxime; Ceftizoxime; Cefuroxime; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Quinolines; Quinolones; Streptococcus pneumoniae	1997
Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:5 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus	1997
Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Penicillins; Quinolines; Quinolones; Streptococcus pneumoniae	1997
In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Quinolones; Ureaplasma urealyticum	1998
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones	1998
Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Fluoroquinolones; Meningitis, Pneumococcal; Moxifloxacin; Pneumococcal Infections; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae	1998
Susceptibilities of Legionella spp. to newer antimicrobials in vitro. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Ketolides; Legionella; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Rifampin	1998
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. International journal of antimicrobial agents, 1998, Volume: 10, Issue:1 Topics: Amoxicillin; Anti-Infective Agents; Aza Compounds; Cefuroxime; Clavulanic Acid; Erythromycin; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillin Resistance; Quinolines; Quinolones; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes	1998
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species. Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Vancomycin	1998
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:7 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Drug Evaluation; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Protein Binding; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin	1998
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, trovafloxacin, and ciprofloxacin. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:7 Topics: Anti-Infective Agents; Aza Compounds; Bordetella; Bordetella pertussis; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Quinolines; Quinolones	1998
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins	1998
Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Cells, Cultured; Ciprofloxacin; Fluoroquinolones; Humans; Leukocytes, Mononuclear; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Phagocytosis; Quinolines; Quinolones; Staphylococcus aureus	1998
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:8 Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Female; Fluoroquinolones; Lung; Mice; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Organ Size; Quinolines; Quinolones; Spleen; Tuberculosis	1998
[New developments in pharmacology of antibiotics]. Presse medicale (Paris, France : 1983), 1998, Volume: 27 Suppl 5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Disease Models, Animal; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Moxifloxacin; Quinolines; Quinolones; Thienamycins	1998
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin	1999
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States. Diagnostic microbiology and infectious disease, 2001, Volume: 39, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Europe; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; United States	2001
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. European journal of haematology, 2001, Volume: 66, Issue:5 Topics: Animals; Anti-Infective Agents; Aza Compounds; Bone and Bones; Bone Marrow Cells; Cell Count; Ciprofloxacin; Culture Media, Conditioned; Culture Techniques; Cyclophosphamide; Cytokines; Disease Models, Animal; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunity; Interleukin-6; Leukocyte Count; Leukopenia; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Quinolines; Quinolones; Spleen; Urinary Bladder	2001
Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Norfloxacin; Quinolines; Quinolones; Streptococcus pneumoniae	2001
Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; DNA Topoisomerases, Type I; Fluoroquinolones; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Quinolones; Staphylococcus aureus	2002
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Biological Transport; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Streptococcus pneumoniae	2002
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1 Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones	2002
In vitro activities of newer quinolones against bacteroides group organisms. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10 Topics: Anti-Infective Agents; Aza Compounds; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Quinolines; Quinolones	2002
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1 Topics: Animals; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Indoles; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance	2003
Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters. Chemotherapy, 2002, Volume: 48, Issue:6 Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Time Factors	2002
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones	2003
Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Anti-Infective Agents; Aza Compounds; Chlamydophila pneumoniae; DNA Gyrase; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Indoles; Levofloxacin; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Topoisomerase II Inhibitors	2003
Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk. European journal of pharmacology, 2003, Sep-05, Volume: 477, Issue:1 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Ciprofloxacin; Dioxolanes; DNA-Binding Proteins; Dogs; Fluoroquinolones; In Vitro Techniques; Moxifloxacin; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Quinolines; Quinolones; Telemetry; Trans-Activators; Transcriptional Regulator ERG	2003
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. Chemotherapy, 2004, Volume: 50, Issue:1 Topics: Abdominal Injuries; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Aerobic; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Wound Infection	2004
Serine-to-asparagine substitution in the GyrA gene leads to quinolone resistance in moxifloxacin-exposed Chlamydia pneumoniae. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:1 Topics: Anti-Infective Agents; Asparagine; Aza Compounds; Chlamydophila pneumoniae; DNA Gyrase; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Point Mutation; Quinolines; Quinolones; Serial Passage; Serine	2005
Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae	2005
Vibrational spectroscopic characterization of fluoroquinolones. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2005, Volume: 61, Issue:7 Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water	2005
[Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains]. Problemy tuberkuleza i boleznei legkikh, 2005, Issue:2 Topics: Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Liver; Lung; Mice; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2005
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Cell Line; Ciprofloxacin; Fluoroquinolones; Heat-Shock Response; Humans; Kinetics; Levofloxacin; Macrophages; Moxifloxacin; Ofloxacin; Quinolines; Quinolones	2005
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:2 Topics: Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Quinolones; Sampling Studies; Sensitivity and Specificity	2005
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. International journal of antimicrobial agents, 2005, Volume: 26, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cystic Fibrosis; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Opportunistic Infections; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Quinolones	2005
[The basic and clinical studies of moxifloxacin: the profile as respiratory quinolones]. The Japanese journal of antibiotics, 2005, Volume: 58, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Respiratory System Agents; Safety	2005
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes	2006
In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5 Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Fluoroquinolones; Humans; In Vitro Techniques; Inhibitory Concentration 50; Linezolid; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Pyrrolidines; Quinolines; Quinolones; Thienamycins	2006
In vitro activities of DX-619 and comparison quinolones against gram-positive cocci. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Enterococcus; Fluoroquinolones; Gatifloxacin; Gram-Positive Cocci; In Vitro Techniques; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pyrrolidines; Quinolines; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes	2006
In vitro development of resistance to DX-619 and other quinolones in enterococci. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Polymerase Chain Reaction; Pyrrolidines; Quinolines; Quinolones; Sequence Analysis, DNA	2006
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:6 Topics: Action Potentials; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Fluoroquinolones; Heart Conduction System; In Vitro Techniques; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Rabbits; Torsades de Pointes	2007
Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis. Journal of veterinary pharmacology and therapeutics, 2007, Volume: 30, Issue:5 Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Quinolones; Retrospective Studies; Species Specificity	2007
Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Chlamydia trachomatis; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Genotype; HeLa Cells; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Quinolones; Rifampin	2008
Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. The British journal of ophthalmology, 2008, Volume: 92, Issue:6 Topics: Aza Compounds; Conjunctiva; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, MDR; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Staphylococcus epidermidis	2008
Facilitated permeation of antibiotics across membrane channels--interaction of the quinolone moxifloxacin with the OmpF channel. Journal of the American Chemical Society, 2008, Oct-08, Volume: 130, Issue:40 Topics: Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Models, Molecular; Moxifloxacin; Porins; Protein Binding; Protein Structure, Tertiary; Quinolines; Quinolones; Spectrometry, Fluorescence	2008
Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population. The International journal of artificial organs, 2008, Volume: 31, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Naphthyridines; Prosthesis-Related Infections; Quinolines; Quinolones; Staphylococcal Infections; Staphylococcus epidermidis	2008
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India. Eye (London, England), 2010, Volume: 24, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Retrospective Studies; Staphylococcus; Streptococcus	2010
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nature structural & molecular biology, 2009, Volume: 16, Issue:6 Topics: Anti-Infective Agents; Antigens, Neoplasm; Aza Compounds; DNA; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Bacterial; Fluoroquinolones; Models, Molecular; Molecular Conformation; Moxifloxacin; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolines; Quinolones; Streptococcus pneumoniae	2009
Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009, Dec-01, Volume: 877, Issue:31 Topics: Anti-Bacterial Agents; Aza Compounds; Calibration; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluorescence; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Reproducibility of Results	2009
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan	2010
Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3 Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Aza Compounds; Chloramphenicol; Escherichia coli; Fluoroquinolones; Microbial Viability; Moxifloxacin; Oxolinic Acid; Quinolines; Quinolones; Reactive Oxygen Species	2010
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline	2010
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin	2012
Resistance of M. leprae to quinolones: a question of relativity? PLoS neglected tropical diseases, 2013, Volume: 7, Issue:11 Topics: Animals; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Leprosy; Mice; Moxifloxacin; Mycobacterium leprae; Quinolines; Quinolones	2013
Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA, Bacterial; Escherichia coli; Fluoroquinolones; Moxifloxacin; Mycobacterium tuberculosis; Quinolones	2014
In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey. Infectious diseases (London, England), 2015, Volume: 47, Issue:6 Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Doxycycline; Fluoroquinolones; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Quinolones; Serotyping; Turkey	2015
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polymerase Chain Reaction; Pyrrolidines; Quinolones; Ribotyping	2017
Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates. Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Intensive Care Units; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Quinolones	2017
Clearance of Mycoplasma genitalium Infection With Moxifloxacin in the Presence of Quinolone Resistance-Associated Mutations. Sexually transmitted diseases, 2020, Volume: 47, Issue:3 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Quinolones; Retrospective Studies; Treatment Outcome	2020
Quinolone Resistance-Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time. Sexually transmitted diseases, 2020, Volume: 47, Issue:3 Topics: Drug Resistance, Bacterial; Humans; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Quinolones	2020
Basophil activation test in the diagnosis of hypersensitivity reactions to quinolones in a real-life setting. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021, Volume: 51, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Basophil Degranulation Test; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Norfloxacin; Quinolones; Skin Tests; Young Adult	2021
Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system. Expert opinion on drug safety, 2022, Volume: 21, Issue:2 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Moxifloxacin; Pharmacoepidemiology; Pharmacovigilance; Quinolones; Retinal Detachment; Risk; Sensitivity and Specificity; United States; United States Food and Drug Administration; Young Adult	2022
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg). Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:10 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Penicillins; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Tetracycline	2022
Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis. International journal of environmental research and public health, 2022, 04-15, Volume: 19, Issue:8 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cost-Benefit Analysis; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Tuberculosis, Pulmonary	2022
Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta. BMC microbiology, 2022, 10-18, Volume: 22, Issue:1 Topics: Amino Acids; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Quinolones; Salmonella; Salmonella enterica; Salmonella typhi; Typhoid Fever	2022
Occurrence, distribution, and risk assessment of quinolone antibiotics in municipal sewage sludges throughout China. Journal of hazardous materials, 2023, 07-05, Volume: 453 Topics: Anti-Bacterial Agents; China; Environmental Monitoring; Humans; Moxifloxacin; Ofloxacin; Quinolones; Risk Assessment; Sewage; Water Pollutants, Chemical	2023
[The problem of formation of new risks of medicinal resistance of patients with tuberculosis in condition of active use of antibiotics by population under COVID-19]. Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny, 2023, Volume: 31, Issue:2 Topics: Anti-Infective Agents; Antitubercular Agents; Azithromycin; COVID-19; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Mycobacterium tuberculosis; Pandemics; Quinolones; Tuberculosis	2023